NCT04824118 - Clotting Parameters After Medical Abortion | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 26, 2021

Primary Completion Date

August 12, 2021

Study Completion Date

August 12, 2021

Conditions

Abortion EarlyAbortion, CompleteAbortion, Second TrimesterTermination of Pregnancy Complicated by EmbolismVenous ThrombosesVenous ThromboembolismVenous Thromboembolic DiseaseClotting Disorder

Interventions

DIAGNOSTIC_TEST

Thromboelastometry

Point of Care Test for clotting parameters (ClotPro device)

DIAGNOSTIC_TEST

Clotting Studies

"Standard laboratory tests for clotting:~* International normalised ratio (INR)~* Prothrombin time (PT)~* adjusted partial thromboplastin time (aPTT)~* fibrinogen"

DIAGNOSTIC_TEST

Full Blood Count

For platelet count

DIAGNOSTIC_TEST

Quantitative hCG

Serum human chorionic gonadotrophin

DIAGNOSTIC_TEST

Pregnancy Test

Point of care urinary pregnancy test

Trial Locations (1)

EH39ES

Chalmers Centre for Sexual and Reproductive Health, Edinburgh

All Listed Sponsors

collaborator

University of Edinburgh

OTHER

lead

NHS Lothian

OTHER_GOV